Home/Capacity Bio/Orian Shirihai, MD, PhD

OS

Orian Shirihai, MD, PhD

Scientific Advisor

Therapeutic Areas

Mitochondrial Dysfunction Aging Neurodegenerative Diseases Metabolic Diseases

Capacity Bio Pipeline

Drug	Indication	Phase
Mitophagy Agonist	Undisclosed (Mitochondrial Dysfunction)	Pre-clinical

Leadership Team at Capacity Bio

Chief Executive Officer

Chief Operating Officer

Chief Financial Officer

Kevin Gaffney, PhD

Chief Scientific Officer

Kathleen Rodgers, PhD

Chief Medical Officer

View full Capacity Bio profile